Here's a look at the characteristic methods of communication among patients with BPD.

Eisai and Biogen announced they have initiated a rolling submission for subcutaneous Leqembi for Alzheimer disease.

Experience is an end in itself, not measured in time or goals.

Celebrating the life and smile of Herbert Pardes, MD.

Learning to use a psychedelic agent can be challenging when the protocols are not defined. Here’s how a psychiatrist got started.

Remembering the many ways Carl I. Cohen, MD, added to the field of psychiatry.

Here’s a look at our recent coverage of these disorders in honor of Mother’s Day 2024.

Here are highlights from the week in Psychiatric Times.

What is new in research on stress and anxiety disorders?

Here's what you need to do following big conferences like the 2024 APA Annual Meeting.

Gone in a puff of smoke? Researchers investigated the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis and co-occurring CUD.

H. Steven Moffic, MD, received the Abraham Halpern Humanitarian Award at the 2024 American Psychiatric Association Annual Meeting. Here’s what he spoke about during his acceptance.

“The wind has donned your hair...

Here’s how an integrated psychosocial and pharmacologic approach can enhance SUD treatment.

According to the chief medical officer of MindMed, it is time to look past the history of LSD.

The psilocybin did well on safety and efficacy in this phase 2 trial of patients with PTSD.

Pharmacogenomics at the 2024 APA Annual Meeting.

Sudhakar K. Shenoy, MD, discusses annual meeting, hot topics in child and adolescent psychiatry, and other issues in psychiatry.

Can you form a human bond virtually?

Biases can be apparent in case notes. Psychiatric Times Editor-in-Chief sat down with us at the 2024 APA Annual Meeting to share more.

TEV-‘749, an investigational once-monthly subcutaneous long-acting injection of the 2nd generation antipsychotic olanzapine, sees positive phase 3 results.

A comprehensive discussion on new treatment options for patients with schizophrenia, highlighting the potential for earlier intervention to optimize treatment outcomes.

Here are highlights from the last day of this year’s APA Annual Meeting.

H. Steven Moffic, MD: winner of the Abraham Halpern Humanitarian Award at the 2024 APA Annual Meeting.